Extension to Covid medicine PBS listing

Government announces a new demographic cohort will have PBS access to an anti-COVID medication The Federal government has announced that, from 1 July, the eligibility criteria for PBS access to Paxlovid (nirmatrelvir and ritonavir) will expand to include people aged 50-59 years of age with mild to moderate COVID-19, and with one additional risk factor

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous The top twenty
Next New NAPSA leadership revealed